| |
Cardiovascular
We have a non surgical alternative for bypass surgery, angioplasty and stent placement. It’s a form of therapy called Chelation.
What Is Chelation?
Chelation therapy is a series of intravenous infusion treatments using EDTA (ethylene diamine tetra-acetic acid), a synthetic amino acid which has the ability to "bond" or "hook onto" molecules of calcium, lead, cadmium, mercury and some of the trace minerals. When the EDTA combines with these minerals in your circulatory system, they are filtered out through the kidneys and eliminated from the body in the urine.
Arteriosclerosis, a medical condition caused by chronic changes in the arterial walls, eventually produces obstructions to the blood flow. The mechanism of action of chealtion treatments is still debated as is frequently true in all medical treatments, but nonetheless there clinically is an increase in the oxygenated blood supply to every cell and tissue in the body.
Our Protocol
The chelation therapy protocol that we administer at The Hills Medical Group has been developed in accordance with The American College for the Advancement in Medicine (ACAM). Founded in 1973, ACAM is a non-profit corporation, primarily engaged in researching the treatment of coronary artery disease and its related conditions. Approximately 750 licensed physicians have safely treated over 500,000 patients in this country, utilizing the protocol developed by ACAM.
The Hills Medical Group also recommends a comprehensive approach in conjunction with the chelation protocol which includes lifestyle changes such as a healthy diet, regular exercise, stress management, increased rest and sleep, and avoiding detrimental substance usage (e.g. alcohol, tobacco, caffeine, etc.)
How Many Treatments Will I Receive?
Although the number of intravenous infusions for optimal therapeutic benefit varies with each patient, the routine regimen is a series of 30 infusions given once or twice weekly with a period of at least 24 hours between sessions. After the initial program of 30 infusions, it is recommended that the patient continue to receive intravenous therapy once or twice a month for one year to sustain improvements in physical parameters, then one time every three months thereafter for maintenance as determined by our credentialed medical staff.
|
|
